0001144204-12-059348.txt : 20121105
0001144204-12-059348.hdr.sgml : 20121105
20121105105510
ACCESSION NUMBER: 0001144204-12-059348
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20121105
DATE AS OF CHANGE: 20121105
EFFECTIVENESS DATE: 20121105
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synthetic Biologics, Inc.
CENTRAL INDEX KEY: 0000894158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133808303
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-186486
FILM NUMBER: 121178913
BUSINESS ADDRESS:
STREET 1: 3985 RESEARCH PARK DRIVE,
STREET 2: SUITE 200
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: (734) 332-7800
MAIL ADDRESS:
STREET 1: 3985 RESEARCH PARK DRIVE,
STREET 2: SUITE 200
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20081027
FORMER COMPANY:
FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20061214
FORMER COMPANY:
FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19970730
D
1
primary_doc.xml
X0706
D
LIVE
0000894158
Synthetic Biologics, Inc.
617 DETROIT STREET, SUITE 100
ANN ARBOR
MI
MICHIGAN
48108
(734) 332-7800
NEVADA
Adeona Pharmaceuticals, Inc.
ADEONA PHARMACEUTICALS, INC.
PIPEX PHARMACEUTICALS, INC.
SHEFFIELD PHARMACEUTICALS INC
Corporation
true
Jeffrey
Riley
c/o Synthetic Biologics
617 Detroit Street, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Executive Officer
Director
C.
Evan
Ballantyne
c/o Synthetic Biologics
Ann Arbor
MI
MICHIGAN
48104
Executive Officer
Jeffrey
Kraws
c/o Synthetic Biologics
617 Detroit Street, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Jeffrey
Wolf
c/o Synthetic Biologics
617 Detroit Street, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Steve
Kanzer
c/o Synthetic Biologics, Inc.
617 Detroit Street, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Scott
Tarriff
c/o Synthetic Biologics
617 Detroit Street, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Biotechnology
Decline to Disclose
- 06
false
2012-10-30
false
true
false
0
Griffin Securities, Inc.
43229
None
None
17 STATE STREET
NEW YORK
NY
NEW YORK
10004
CA
CALIFORNIA
CT
CONNECTICUT
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
TX
TEXAS
VT
VERMONT
VA
VIRGINIA
false
10800000
10800000
0
false
22
648000
0
In addition to cash fees, the Placement Agent received warrants to acquire an aggregate of 635,855 shares of common stock.
0
false
Synthetic Biologics, Inc.
/s/ Jeffrey Riley
Jeffrey Riley
President and Chief Executive Officer
2012-11-05